After the European Central Bank announced the interest rate decision, EUR/USD rose 15 points to 1.0484.In the direction of pan-consumption, there were more than 50 stocks with daily limit, and the concept of big consumption continued to strengthen. Retail, food, home, ice and snow industries and other branches set off a wave of daily limit, and Zhongbai Group, Youhao Group, Huifa Food, Panda Dairy, Wole Home and Meike Home exceeded 50 stocks with daily limit.Reuters survey: Most economists believe that the tariff proposed by US President-elect Trump has little impact on the British economy; It is estimated that the Bank of England will cut interest rates by 100 basis points in 2025, and may cut interest rates by 25 basis points every quarter; A survey of 71 interviewed economists shows that the Bank of England's interest rate is expected to remain unchanged at 4.75% on December 19th.
Shenzhen Energy Investment established a new energy development company, and the enterprise search APP showed that recently, Shenneng (Zhuolu) New Energy Development Co., Ltd. was established, with Li Xuedong as the legal representative and a registered capital of 2 million yuan. Its business scope includes: solar power generation technical services; Technical services for wind power generation; Research and development of wind farm related systems; Energy storage technology services, etc. Enterprise survey shows that the company is indirectly wholly-owned by Shenzhen Energy.European Central Bank: It plans to stop reinvesting in the Emergency Anti-epidemic Bond Purchase Program (PEPP) by the end of 2024. Continue to reduce the emergency anti-epidemic bond purchase program (PEPP) by 7.5 billion euros per month.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)
South Korea's National Election Commission: South Korean President Yin Xiyue's remarks undermined South Korea's electoral system.Market News: The Slovak Prime Minister said that Slovakia supports the normalization of relations between Russia and western countries and opposes the emergence of a new iron curtain in Europe. The Slovak Prime Minister emphasized that all conflicts will be finally resolved through negotiations.The Baltic dry bulk freight index fell 4.61% to 1055 points.